Aktis Oncology, Inc.
NASDAQ:AKTSBiotechnology
Healthcare
$16.10 +0.47%
+$0.11 today
- Market cap
- $865.32M
- Beta
- 1.10
- P/E (TTM)
- -28.7
- EPS (TTM)
- -$0.82
52W Low $14.72High $29.16
Volume 0.44M
Average 0.33M
Price history
Aktis Oncology, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-28.12%
Period high
$32.23
Period low
$14.59
Latest
$16.10
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 12, 2026 | Nov 12, 2026 | |
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| 4 | Sep 24, 2026 | Sep 24, 2026 | |
| 10-Q | Aug 13, 2026 | Aug 13, 2026 | |
| 8-K | Aug 13, 2026 | Aug 13, 2026 | |
| 4 | Jul 21, 2026 | Jul 21, 2026 | |
| 4 | Jul 20, 2026 | Jul 20, 2026 | |
| 144 | Jul 20, 2026 | Jul 20, 2026 | |
| 144 | Jul 17, 2026 | Jul 17, 2026 | |
| 4 | Jul 10, 2026 | Jul 10, 2026 | |
| 4 | Jul 10, 2026 | Jul 10, 2026 | |
| 144 | Jul 8, 2026 | Jul 8, 2026 | |
| 144 | Jul 8, 2026 | Jul 8, 2026 | |
| SC 13G | May 14, 2026 | May 14, 2026 | |
| 10-Q | May 11, 2026 | May 11, 2026 |
Competitors
Who does Aktis Oncology, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about AKTS's filings, answered from its disclosures.
What is the latest AKTS filing?
The latest filing shown is 8-K dated Nov 12, 2026.
How many recent filings does AKTS have?
Intrinsic Alpha currently shows 20 recent filings for AKTS.
Continue the stock analysis
Jump to another research area for this company.